首页> 外文期刊>Melanoma research >The programmed cell death protein-1/programmed cell death ligand 1 expression, CD3+ T cell infiltration, NY-ESO-1 expression, and microsatellite instability phenotype in primary cutaneous melanoma and mucosal melanoma and their clinical significance and prognostic value: a study of 89 consecutive cases
【24h】

The programmed cell death protein-1/programmed cell death ligand 1 expression, CD3+ T cell infiltration, NY-ESO-1 expression, and microsatellite instability phenotype in primary cutaneous melanoma and mucosal melanoma and their clinical significance and prognostic value: a study of 89 consecutive cases

机译:编程的细胞死亡蛋白-1 /编程的细胞死亡配体1表达,CD3 + T细胞浸润,NY-ESO-1表达和初级皮肤黑素瘤和粘膜黑素瘤的微卫星不稳定性表型及其临床意义和预后价值:89的研究 连续案件

获取原文
获取原文并翻译 | 示例
           

摘要

We evaluated the expression of programmed cell death protein-1 (PD-1), programmed cell death ligand 1 (PD-L1), and NY-ESO-1 antigen; the infiltration of CD3+ T cells; and the microsatellite instability (MSI) phenotype, as well as the relationship of each factor to survival in malignant melanoma patients. Malignant melanoma samples from 89 patients were stained by immunohistochemistry to evaluate PD-1, PD-L1, CD3+ tumor-infiltrating lymphocytes (TILs), NY-ESO-1, and MSI. PD-1 and PD-L1 were expressed in 19.1 and 32.6% of the 89 samples, respectively. There was a significant correlation between PD-1 and PD-L1 expression ( r ?=?0.207, P ?=?0.046). High infiltration of CD3+ T cells was observed in 41.6% of the samples, and increased cell infiltration was associated with increased PD-1 expression ( P ?=?0.001). NY-ESO-1 antigen was detected in 13.5% of all samples, and the expression of NY-ESO-1 was positively correlated with the expression of PD-1 ( P ?
机译:我们评估了编程细胞死亡蛋白-1(PD-1),编程的细胞死亡配体1(PD-L1)和NY-ESO-1抗原的表达; CD3 + T细胞的渗透;和微卫星不稳定性(MSI)表型,以及恶性黑素瘤患者中生存率的每个因素的关系。 89例患者的恶性黑素瘤样品通过免疫组织化学染色,评价PD-1,PD-L1,CD3 +肿瘤浸润淋巴细胞(TIL),NY-ESO-1和MSI。 PD-1和PD-L1分别在19.1和32.6%的89个样品中表达。 PD-1和PD-L1表达式之间存在显着的相关性(R?= 0.207,P?= 0.046)。在41.6%的样品中观察到CD3 + T细胞的高浸润,并且增加的细胞浸润与增加的PD-1表达(P?= 0.001)相关。在所有样品的13.5%中检测到NY-ESO-1抗原,并且NY-ESO-1的表达与PD-1的表达呈正相关(p?<0.001)。在我们的研究中,MSI在18个样品中检测到(20.2%)。存活分析表明,CD3 + T细胞的高浸润与无进展的存活率相关(PFS)[24.0吗?月,95%置信区间(CI):7.4-40.6与11.0个月,95%CI:7.1-12.9 ,P?= 0.031],类似,CD3 + T细胞高渗患者的中值整体存活(OS)也更长(53.0与38.0个月),但没有统计学意义(P?= 0.200)。上述免疫标志物的结果为恶性黑素瘤患者的预后和免疫疗法选择提供了理论依据。

著录项

  • 来源
    《Melanoma research》 |2020年第1期|共17页
  • 作者单位

    Department of the Comprehensive Cancer Center Drum Tower Hospital the Affiliated Hospital of;

    Yi Xing Tumor Hospital;

    Department of the Comprehensive Cancer Center Drum Tower Hospital the Affiliated Hospital of;

    Department of the Comprehensive Cancer Center Drum Tower Hospital the Affiliated Hospital of;

    Department of the Comprehensive Cancer Center Drum Tower Hospital the Affiliated Hospital of;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号